75N95022C00007↗

University of Utah received this contract from National Institutes of Health Nida, National Institutes of Health: $22.28M obligated so far for health r&d services; health care services; basic research. It runs to 2026-12-31, or to 2027-12-31 if every option is exercised.

Key facts · data as of Oct 25, 2026

Recipient
University of Utah
Awarding agency
National Institutes of Health (Department of Health and Human Services)
Contracting office
National Institutes of Health Nida (75N950)
Obligated to date
$22.28M
Potential value
$32.98M
Ends
2026-12-31

Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.

Cite this page: SpendQuery, Award 75N95022C00007, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_AWD_75N95022C00007_7529_-NONE-_-NONE-

SCREENING OF INVESTIGATIONAL THERAPEUTICS TO TREAT, MODIFY OR PREVENT EPILEPSY FOR THE NINDS EPILEPSY THERAPY SCREENING PROGRAM (ETSP)

Definitive Contract · National Institutes of Health · to University of Utah (UEI LL8GLEVH6MG3) · data as of 2026-10-25

Obligated to date$22.28M6 actions
Current value$26.49Mwith options exercised
Potential value$32.98Mif every option is used
Period2022-03-22 → 2026-12-31up to 2027-12-31 with options

Up for re-bid: ends 2026-12-31. Recompete brief → · Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories ↗

What it is

Product or service
Health R&D Services; Health Care Services; Basic Research (PSC AN11)
Industry
Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) (NAICS 541715)
Contracting office
National Institutes of Health Nida (75N950)
Competition
Full and open competition · 1 offer received
Pricing
Cost no fee
How it was bought
Standalone contract
Solicitation
75N95022R00005
Where the work is
Salt Lake, UT · district UT-01

Obligations by fiscal year

FY2023$5.50M
FY2024$5.75M
FY2025$5.40M
FY2026$5.63M

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

6 actions since 2022-12-20. Each is a modification or amendment with the money it added or took back.

DateModificationKindAmountWhat the agency wrote
2026-08-20P00007Administrative change$0SCREENING OF INVESTIGATIONAL THERAPEUTICS TO TREAT, MODIFY OR PREVENT EPILEPSY FOR THE NINDS EPILEPSY THERAPY SCREENING PROGRAM (ETSP)
2026-04-27P00006Administrative change$0SCREENING OF INVESTIGATIONAL THERAPEUTICS TO TREAT, MODIFY OR PREVENT EPILEPSY FOR THE NINDS EPILEPSY THERAPY SCREENING PROGRAM (ETSP)
2025-12-11P00005Option exercised$5.63MSCREENING OF INVESTIGATIONAL THERAPEUTICS TO TREAT, MODIFY OR PREVENT EPILEPSY FOR THE NINDS EPILEPSY THERAPY SCREENING PROGRAM (ETSP)
2024-12-19P00004Option exercised$5.40MSCREENING OF INVESTIGATIONAL THERAPEUTICS TO TREAT, MODIFY OR PREVENT EPILEPSY FOR THE NINDS EPILEPSY THERAPY SCREENING PROGRAM (ETSP)
2023-12-27P00003Option exercised$5.75MSCREENING OF INVESTIGATIONAL THERAPEUTICS TO TREAT, MODIFY OR PREVENT EPILEPSY FOR THE NINDS EPILEPSY THERAPY SCREENING PROGRAM (ETSP)
2022-12-20P00002Option exercised$5.50MSCREENING OF INVESTIGATIONAL THERAPEUTICS TO TREAT, MODIFY OR PREVENT EPILEPSY FOR THE NINDS EPILEPSY THERAPY SCREENING PROGRAM (ETSP)

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗